MDLinx
VerifiedOnline/Digital
MDLinx is an internet-based service for physicians and healthcare professionals provided by M3 USA Corporation. It offers physicians and other healthcare professionals a means of staying current with academic literature. Source
Actions
Media Outlet details
| Scope | International |
|---|---|
| Language | English |
| Country | United States of America |
|
Similarweb UVM |
Request pricing |
|
Comscore UVM |
Request pricing |
Recent Articles
Search ArticlesThis page could not be found
This page could not be found .
The military's new testosterone policy has doctors asking: Who will manage the fallout?
This is non-evidence-based and could cause harm. —Adriane Fugh-Berman, MD This will do fantastic things for the large number of men already coming to me convinced that their T is low and then going to some online men's clinic to get testosterone when I tell them that their levels are normal and they need a sleep study.
Physicians in these specialties are the happiest—is yours on the list?
By reducing administrative burden and advancing evidence-based solutions, we can help physicians rediscover the joy in medicine while building more sustainable practice environments. —Bobby Mukkamala, MD, via AMA A long-time subject of hot debate among physicians: Which specialties offer the best quality of life? Is it dermatology, with its predictable hours? Psychiatry, with growing demand and expanding treatment options?
The herbicide under scrutiny for hormonal harms
While this herbicide isn’t commonly available to the general population, [its] prominence in cornfields has the potential to contaminate drinking water by ending up in streams, rivers, lakes, and wells. —Ann Shippy, MD For years, concerns about endocrine-disrupting chemicals have centered on a difficult but increasingly urgent question for clinicians: What are these exposures doing to human health?
Cyclosporiasis has one preferred treatment. What if your patient can’t take it?
The large multistate Cyclospora outbreak this summer has put this foodborne parasite on clinicians’ radar. As of July 13, the CDC reports 1,645 known cases from 34 states, with 141 hospitalizations.[] Prior outbreaks have been linked primarily to fresh produce. Physicians across the country are now evaluating an influx of patients with "explosive diarrhea" lasting 1 to 2 weeks—sometimes longer. [] For most clinicians, making the diagnosis is only half the battle.
The FDA’s latest psychedelics guidance could reshape future clinical trials
As interest in psychedelic therapies grows, strong science must lead the way. This new guidance helps ensure patients can access therapies that uphold the FDA’s gold standard for safety and effectiveness. —Michael Davis, MD, PhD, via X Interest in psychedelic therapies has accelerated over the past several years, fueled by promising early data in conditions such as treatment-resistant depression, post-traumatic stress disorder (PTSD), and substance use disorders.
Could Bryan Johnson be the first person to 'biohack himself to death'? Why physicians should pay attention
Patients should be extremely skeptical of claims made by anyone who suggests that specific protocols can induce or treat any form of autoimmune disease based solely on anecdotal experience, without rigorous scientific evidence. —Michael DeShields, MD Bryan Johnson has built a public identity around measurement: Sleep, biomarkers, imaging, supplements, diet, body composition, biological age, all tracked and posted.
Ruminating about a work decision? This oncologist gets honest about self-doubt
When I was a resident, I’d often drive home in silence and wonder if I’d made the right decisions for my patients that day. If I’d said the right words. If I could’ve done anything differently. —Laura Vater, MD, oncologist On a recent Instagram post, oncologist Laura Vater, MD, offered a glimpse into something most doctors experience but rarely talk about: the mental load of patient care.
HHS pushes ahead with effort to curb antidepressant use: What physicians should know—and how to respond
With antidepressants, we do not see a tendency for compulsive use. People don’t take them and say, ‘Oh, my gosh, that feels great. I wonder if I take two, maybe three, how that would feel?’ It’s just not happening. —Andrew Novick, MD The entire American medical system downplays mental health. —Scott Thompson, PhD The debate over antidepressants in America isn’t slowing down.